Hematopoietic cell transplantation-specific comorbidity index to predict non-relapse mortality and survival after allografting.

被引:1
|
作者
Kato, R [1 ]
Fukuda, T [1 ]
Usui, E [1 ]
Yamasaki, S [1 ]
Maruyama, D [1 ]
Morita, Y [1 ]
Kim, SW [1 ]
Mori, SI [1 ]
Tanosaki, R [1 ]
Tajima, K [1 ]
Heike, Y [1 ]
Makimoto, A [1 ]
Tobinai, K [1 ]
Takaue, Y [1 ]
机构
[1] Natl Canc Ctr, Hematopoiet Cell Transplantat Unit, Tokyo, Japan
关键词
D O I
10.1182/blood.V106.11.2731.2731
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2731
引用
收藏
页码:766A / 767A
页数:2
相关论文
共 50 条
  • [41] Pre-Transplantation ST2 Levels and Non-Relapse Mortality after Myeloablative Allogeneic Hematopoietic Cell Transplantation
    Gjaerde, Lars Klingen
    Ostrowski, Sisse Rye
    Andersen, Niels Smedegaard
    Friis, Lone Smidstrup
    Kornblit, Brian
    Petersen, Soren Lykke
    Schjodt, Ida
    Sengelov, Henrik
    BLOOD, 2020, 136
  • [42] Hematopoietic Cell Transplantation - Specific Comorbidity Index As An Instrument to Predict Survival in Patients Admitted to Intensive Care Unit Early After Allogeneic Transplantation
    Bayraktar, Ulas D.
    Shpall, Elizabeth J.
    Liu, Ping
    Ciurea, Stefan O.
    De Lima, Marcos
    Rondon, Gabriela
    Price, Kristen J.
    Champlin, Richard
    Nates, Joseph L.
    BLOOD, 2011, 118 (21) : 71 - 71
  • [43] Social Economic Status Is Associated with a Lower Non-Relapse Mortality Rate and an Increased Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation
    Galvin, John P.
    Ehrlich, Katherine
    Baveja, Swati
    Scheide, Thomas
    Valukas, Catherine
    Penedo, Frank
    Miller, Greg
    Mehta, Jayesh
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S175 - S176
  • [44] Early Prognostic Biomarkers of Non-Relapse Mortality in Allogeneic Mismatched Unrelated Hematopoietic Cell Transplantation
    Wang, Trent
    Crawford, Anna
    Fu, Denggang
    Hill, Elizabeth
    Jimenez, Antonio M. Jimenez
    Komanduri, Krishna V.
    Paczesny, Sophie
    BLOOD, 2023, 142
  • [45] Duration of first remission and hematopoietic cell transplantation-specific comorbidity index but not age predict survival of patients with AML transplanted in CR2: a retrospective multicenter study
    F V Michelis
    E G Atenafu
    S Couban
    J Frazer
    S Shivakumar
    D E Hogge
    C L Toze
    W Rajkhan
    H J Kim
    A Daly
    J Slaby
    J Finke
    T Kiss
    C Bredeson
    M Sabloff
    D Sheppard
    M Bakkar
    M Brune
    D A Wall
    K Paulson
    G Popradi
    I Walker
    H A Messner
    Bone Marrow Transplantation, 2016, 51 : 1019 - 1021
  • [46] The impact of individual comorbidities on non-relapse mortality following allogeneic hematopoietic stem cell transplantation
    Joshua A. Fein
    Avichai Shimoni
    Myriam Labopin
    Noga Shem-Tov
    Ronit Yerushalmi
    Hila Magen
    Nadav Furie
    Eli Kopel
    Ivetta Danylesko
    Arnon Nagler
    Roni Shouval
    Leukemia, 2018, 32 : 1787 - 1794
  • [47] The haematopoietic cell transplantation-specific Co-morbidity Index and non-relapse mortality after reduced intensity conditioning: final analysis from the ALWP of EBMT in AML patients in first complete remission
    Mohty, M.
    Labopin, M.
    Basara, N.
    Comelissen, J. J.
    Tabrizi, R.
    Malm, C.
    Perez-Simon, J.
    Nagler, A.
    Kroeger, N.
    Rio, B.
    Martino, R.
    Eder, M.
    Bilger, K.
    Bunjes, D.
    Socie, G.
    Blaise, D.
    Polge, E.
    Rocha, V.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S12 - S12
  • [48] The impact of individual comorbidities on non-relapse mortality following allogeneic hematopoietic stem cell transplantation
    Fein, Joshua A.
    Shimoni, Avichai
    Labopin, Myriam
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Magen, Hila
    Furie, Nadav
    Kopel, Eli
    Danylesko, Ivetta
    Nagler, Arnon
    Shouval, Roni
    LEUKEMIA, 2018, 32 (08) : 1787 - 1794
  • [49] Easix-1yearas a Prognostic Index for Late Non-Relapse Mortality after Allogenichematopoietic Cell Transplantation
    Takeda, Rui Carrie
    Shibasaki, Yasuhiko
    Katagiri, Takayuki
    Fuse, Kyoko
    Sone, Hirohito
    Masuko, Masayoshi
    BLOOD, 2021, 138
  • [50] Non-Relapse Mortality and Quality of Life with Shared Care after Allogeneic Hematopoietic Cell Transplantation: A Randomized Control Trial
    Abel, Gregory A.
    Kim, Haesook T.
    Zackon, Ira
    Alyea, Edwin P., III
    Bailey, Alexandra
    Winters, John P.
    Meehan, Kenneth R.
    Reagan, John L.
    Walsh, Jeanna
    Faggen, Meredith
    Sinclair, Sarah
    Joyce, Amy
    Close, Sara
    Emmert, Amy
    Kallassy, Isabella
    Koreth, John
    Antin, Joseph H.
    Cutler, Corey
    Ho, Vincent T.
    Soiffer, Robert J.
    BLOOD, 2022, 140 : 2135 - 2136